HIV Diagnostics Market share to reach $4.9bn by 2023 PowerPoint PPT Presentation

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: HIV Diagnostics Market share to reach $4.9bn by 2023


1
HIV Diagnostics Market share to reach 4.9bn by
2023Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from HIV Diagnostics Market
  • Global HIV Diagnostics Market size contributed
    about 2.41 billion for 2015 and is expected to
    register CAGR of about 9.6 by end of forecast
    period.
  • Rising cases of HIV (human immunodeficiency
    virus) and fast medical breakthroughs in terms of
    point of care diagnostics is predicted to drive
    HIV diagnostics market trends during forecast
    timeline.
  • HIV is found to be most common ailment,
    particularly in resource limited areas due to low
    health consciousness among the people and
    successful execution of antiretroviral treatment
    program.
  • Global HIV diagnostics industry is segmented into
    various products like viral load, early infant
    diagnosis, antibody tests, viral identification
    assay and CD4.
  • Antibody tests segment is sub-segmented into
    western blot tests, HIV-1 screening tests, dried
    blood spot tests, ELISA (enzyme linked
    immunosorbent assay) tests, HIV- confirmatory
    tests, rapid test, western blot tests, line
    immunoassay, blood anti body tests, RIPA (radio
    immuno precipitation assay) tests, HIV-2 group
    O tests and indirect immunofluorescent antibody
    assay (IIFA) tests.

3
Continued...
  • This segment is predicted to contribute largely
    to HIV diagnostics market share during forecast
    timeline and is projected to surpass 1.6 billion
    by end of 2023.
  • Viral identification assay segment is
    sub-segmented into viral culture, p24 antigen and
    qualitative PCR (polymerase chain reaction).
    Viral culture assay sub segment projected to
    touch 530 million by end of 2023 led the
    segment.
  • Viral load and CD4 segments are projected to
    register comparatively high CAGR of 9.91 and
    10.2 during forecast timeline owing to
    increasing industry penetration as well as
    expansion of point of care diagnostics methods
    for such tests that would improve marketability
    in limited resource settings.
  • North America HIV diagnostics market price was
    evaluated at 947 million for 2015 and it
    dominated the global industry during the year.
  • Asia Pacific HIV diagnostics industry is
    projected to register CAGR of 10.8 during
    forecast timeline due to enhancement in
    healthcare services coupled with rise in levels
    of HIV consciousness amongst the population of
    the region.

4
Table of Content
Chapter 1. Methodology and Scope 1.1.
Methodology
1.1.1. Initial data exploration 1.1.2.
Statistical modeling and forecast 1.1.3.
Industry insights and validation
1.2. Data
Sources Chapter 2. Executive Summary 2.1.
HIV diagnostics industry 3600 synopsis, 2012
- 2023 2.1.1. Business trends 2.1.2.
Regional trends 2.1.3. Application trends
5
Table of Content
Chapter 3. HIV Diagnostics Industry
Insights 3.1. Industry
segmentation 3.2. Industry size and
forecast, 2012 - 2023 3.3. Industry
impact forces 3.3.1. Growth
drivers 3.3.1.1. Favorably regulatory
landscape 3.3.1.2. PoC HIV diagnostics
development 3.3.1.3. Increasing HIV/AIDS
prevalence 3.3.2. Industry pitfalls
challenges 3.3.2.1. Low degree of penetration
in undeveloped regional markets 3.4.
Growth potential analysis 3.5. Porters
analysis 3.6. PESTEL analysis
6
U.S. HIV Diagnostics Market Size, by Product,
2012 - 2023 (USD Million)

7

Browse Full Market Research Report On HIV
Diagnostics Market _at_ http//bit.ly/2p3JDIj
Request for a Sample of this Research
Report _at_ https//www.gminsights.com/request-sample
/detail/491
8
Stay In Touch Website www.gminsights.com Soci
al Media
Write a Comment
User Comments (0)
About PowerShow.com